drugset / Trial / NCT04197323
Alprostadil Liposomes for Injection for Lower Extremity Arteriosclerosis Obliteran
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a randomized, positive-control, multicenter, multiple-dose, dose-escalation phase II trial
Timeline
- Start
- 2019-10-01
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alprostadil | Unknown | 40 ug | — |
| Subject | Alprostadil | Unknown | 80 ug | — |
| Subject | Alprostadil | Unknown | 120 ug | — |